Hyungwoo Cho

8PUBLICATIONS
41CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Immunogenetics (incl. genetic immunology)Transplantation immunologyPredictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 12, 2026
Anbalcabtagene autoleucel (PD-1 and TIGIT knockdown CD19 CAR-T) for relapsed/refractory large B-cell lymphoma (CRC01-01).

|Sep 30, 2025
Clonal Burden, Immunoglobulin Heavy Chain Variable Gene Somatic Hypermutations, and Immunoglobulin Gene Repertoire in Korean Patients with Chronic Lymphocytic Leukemia Assessed by Next-generation Sequencing.

Taegeun Lee, Daehyun Chu, Miyoung Kim

|Jul 24, 2024
Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients.

Hyeon Mu Jang, Seongman Bae, Jiwon Jung

|Aug 22, 2021
Prognostic value of natural killer cell activity for patients with HER2 + advanced gastric cancer treated with first-line fluoropyrimidine-platinum doublet plus trastuzumab.

Hyungwoo Cho, Min-Hee Ryu, Hyung Eun Lee

|Nov 20, 2020
A prognostic index for extranodal marginal-zone lymphoma based on the mucosa-associated lymphoid tissue International Prognostic Index and serum β2-microglobulin levels.

Hyung-Don Kim, Hyungwoo Cho, Hyehyun Jeong

|Aug 24, 2017
Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy.

Hyungwoo Cho, Dok Hyun Yoon, Jung Bok Lee

Pageof 2

Frequent Collaborators

4 joint publications

Dok Hyun Yoon

2 joint publications

Chan-Sik Park

2 joint publications

Seongsoo Jang

1 joint publications

Jin Seok Kim